Companies: 10,795·Total market cap: $144.5T
Arbutus Biopharma Corporation

Arbutus Biopharma Corporation

ABUSNASDAQHealthcare● Active
$4.29
+$0.05(+1.06%)
Market Cap$846449087
P/E Ratio
52W High$5.1
52W Low$3.04
Overview

Arbutus Biopharma Corporation(ABUS)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ABUS · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$91.47M$122.62M$126.00M$146.91M$155.32M
Net Receivables$1.75M$2.41M$1.78M$1.35M$0.90M
Inventory$0.00M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$94.46M$127.32M$132.03M$151.14M$160.66M
PP&E Net$0.03M$4.36M$6.09M$6.81M$8.07M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$94.62M$131.71M$144.40M$195.42M$204.49M
Liabilities
Short-Term Debt$0.55M$0.00M$0.00M$0.37M$0.00M
Accounts Payable$1.17M$2.32M$3.22M$3.52M$3.17M
Total Current Liabilities$6.01M$15.62M$22.49M$32.86M$11.22M
Long-Term Debt$3.44M$0.00M$6.95M$10.37M$16.30M
Total Liabilities$18.04M$34.34M$38.38M$58.57M$35.05M
Stockholders Equity
Retained Earnings($1380.07M)($1346.57M)($1276.65M)($1203.80M)($1134.35M)
Total Stockholders Equity$76.58M$97.37M$106.02M$136.85M$169.44M
Total Liab & Equity(computed)$94.62M$131.71M$144.40M$195.42M$204.49M
Debt Summary
Total Debt$4.19M$1.29M$8.72M$12.55M$18.91M
Net Debt($13.82M)($35.04M)($17.56M)($18.22M)($90.37M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Arbutus Biopharma Corporation

关于Arbutus Biopharma Corporation(ABUS)资产负债表

Arbutus Biopharma Corporation总资产$0.09B,现金及短期投资$0.09B,总负债$0.02B,总债务$0.00B,股东权益$0.08B。

常见问题

ABUS · 4 问

Arbutus Biopharma Corporation总债务$0.00B,净债务($0.01B)。

ABUS total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10